Thanks to ROS1ders’ Partner Turning Point Therapeutics

Jean Cui (right) and Miriam Cruz (left) of Turning Point Therapeutics
with Janet Freeman-Daily of The ROS1ders

Dear Turning Point Therapeutics,

Thank you so much for inviting me to speak to your employees about my personal ROS1 lung cancer story and the work of The ROS1ders. I truly appreciate your willingness to consider a patient perspective on ways to improve awareness of and access to biomarker testing and clinical trials for cancer patients.

A HUGE thank you for your generous gift to our ROS1ders fundraiser at the nonprofit GO2 Foundation for Lung Cancer!  Your gift will help fund patient-driven research projects like our ROS1 Cancer Model Project, which has already generated four new ROS1 cell lines and three publications for our rare disease.

I look forward to a long and productive partnership as we work together to improve outcomes for all ROS1+ cancers.


Janet Freeman-Daily
Cofounder, The ROS1ders

Published by

Gray Connections

I was diagnosed with non-small cell lung cancer in May 2011. The cancer became metastatic in October 2011. No, I never smoked anything (except a salmon). I've had no evidence of disease since January 2013 thanks to precision medicine, clinical trials, and other patients. ANYONE can get lung cancer. Using my engineering degrees (MIT SBME 1978, Caltech Aeronautics MS 1984 and ENGR 1986), I enjoyed a 20-year career in aerospace systems engineering as a technical translator of sorts: I researched a scientific or engineering subject and helped others understand how this new gizmo could benefit them. In the time I have left, I want to use my skills to help others who have lung cancer, and increase the visibility and knowledge of lung cancer among those who don't. I also study brain research, enjoy traveling, write science fiction, and geek out about all sorts of science stuff.